Neurological improvement predicts clinical outcome after acute basilar artery stroke thrombectomy.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 07 2020
accepted: 13 08 2020
pubmed: 20 8 2020
medline: 12 8 2021
entrez: 20 8 2020
Statut: ppublish

Résumé

Mechanical thrombectomy (MT) is the standard of care for patients with anterior circulation large vessel occlusion. Early neurological improvement (ENI), defined as a reduction of ≥ 8 on the National Institutes of Health Stroke Scale (NIHSS) compared with baseline score, or an NIHSS score of 0 or 1 at 24 h after MT, is a strong predictor of 3-month favorable outcome in such patients. The impact of ENI after MT in stroke patients with basilar artery occlusion (BAO) on 3-month outcome is not clear. We aimed to study the effects of ENI in patients with BAO. We performed a retrospective analysis of a multicenter prospective cohort of all consecutive stroke patients with BAO who underwent MT. We compared clinical outcomes between BAO patient groups according to ENI status. Multivariate analyses were performed to determine the impact of ENI on favorable 90-day outcome (modified Rankin scale score 0-3) and to report factors contributing to ENI. A total of 237 patients were included. ENI was observed in 70 patients (30%). Outcomes were significantly better in ENI-positive patients, with 84% achieving favorable outcome (mRS score 0-3) at 3 months versus 30% for ENI-negative patients (P < 0.0001). In multivariate analysis, ENI was an independent predictive factor associated with higher rates of favorable outcome {odds ratio (OR) 18.12 [95% confidence interval (CI) 3.95-83.10]; P = 0.0001}. Higher number of passes [OR 0.62 (95% CI 0.43-0.89); P = 0.010] and need for stenting [OR 0.27 (95% CI 0.07-0.95); P = 0.041] were negatively associated with ENI. Early neurological improvement on day 1 following MT for BAO is a strong independent predictor of a favorable 3-month clinical outcome.

Sections du résumé

BACKGROUND AND PURPOSE
Mechanical thrombectomy (MT) is the standard of care for patients with anterior circulation large vessel occlusion. Early neurological improvement (ENI), defined as a reduction of ≥ 8 on the National Institutes of Health Stroke Scale (NIHSS) compared with baseline score, or an NIHSS score of 0 or 1 at 24 h after MT, is a strong predictor of 3-month favorable outcome in such patients. The impact of ENI after MT in stroke patients with basilar artery occlusion (BAO) on 3-month outcome is not clear. We aimed to study the effects of ENI in patients with BAO.
METHODS
We performed a retrospective analysis of a multicenter prospective cohort of all consecutive stroke patients with BAO who underwent MT. We compared clinical outcomes between BAO patient groups according to ENI status. Multivariate analyses were performed to determine the impact of ENI on favorable 90-day outcome (modified Rankin scale score 0-3) and to report factors contributing to ENI.
RESULTS
A total of 237 patients were included. ENI was observed in 70 patients (30%). Outcomes were significantly better in ENI-positive patients, with 84% achieving favorable outcome (mRS score 0-3) at 3 months versus 30% for ENI-negative patients (P < 0.0001). In multivariate analysis, ENI was an independent predictive factor associated with higher rates of favorable outcome {odds ratio (OR) 18.12 [95% confidence interval (CI) 3.95-83.10]; P = 0.0001}. Higher number of passes [OR 0.62 (95% CI 0.43-0.89); P = 0.010] and need for stenting [OR 0.27 (95% CI 0.07-0.95); P = 0.041] were negatively associated with ENI.
CONCLUSION
Early neurological improvement on day 1 following MT for BAO is a strong independent predictor of a favorable 3-month clinical outcome.

Identifiants

pubmed: 32812674
doi: 10.1111/ene.14487
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-123

Informations de copyright

© 2020 European Academy of Neurology.

Références

Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 2004; 35: 147-150.
Agarwal S, Cutting S, Grory BM, et al. Redefining early neurological improvement after reperfusion therapy in stroke. J Stroke Cerebrovasc Dis 2020; 29: 104526.
Machumpurath B, Davis SM, Yan B. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome. Cerebrovasc Dis 2011; 31: 278-283.
Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005; 65: 1169-1174.
Heit JJ, Mlynash M, Kemp SM, et al. Rapid neurologic improvement predicts favorable outcome 90 days after thrombectomy in the DEFUSE 3 study. Stroke 2019; 50: 1172-1177.
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (London, England) 2016; 387: 1723-1731.
Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol 2020; 19: 115-122.
Writing Group for the BG, Zi W, Qiu Z, et al. Assessment of endovascular treatment for acute basilar artery occlusion via a nationwide prospective registry. JAMA Neurol 2020; 77: 561-573.
Bouslama M, Haussen DC, Aghaebrahim A, et al. Predictors of good outcome after endovascular therapy for vertebrobasilar occlusion stroke. Stroke 2017; 48: 3252-3257.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
Prabhakaran S, Chen M, Choi JH, et al. Major neurologic improvement following endovascular recanalization therapy for acute ischemic stroke. Cerebrovasc Dis 2008; 25: 401-407.
Nam HS, Lee KY, Han SW, et al. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients. J Neurol Sci 2009; 281: 69-73.
Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013; 44: 2650-2663.
Kaesmacher J, Maegerlein C, Zibold F, Wunderlich S, Zimmer C, Friedrich B. Improving mTICI2b reperfusion to mTICI2c/3 reperfusions: A retrospective observational study assessing technical feasibility, safety and clinical efficacy. Eur Radiol 2018; 28: 274-282.
Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438-441.
Cao Y, Wang S, Sun W, et al. Prediction of favorable outcome by percent improvement in patients with acute ischemic stroke treated with endovascular stent thrombectomy. J Clin Neurosci 2017; 38: 100-105.
Christoforidis G, Mohammad YM, Khadir M, Yang M, Slivka AP. Factors associated with rapid neurological improvement 24 h following intra-arterial thrombolytic treatment for acute ischemic stroke. J Neurointerv Surg 2013; 5: 35-39.
Jeong HS, Kwon HJ, Kang CW, et al. Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke. J Stroke Cerebrovasc Dis 2014; 23: e283-e289.
Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983; 14: 294-301.
Frid P, Drake M, Giese AK, et al. Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study. J Neurol 2020; 267: 649-658.
Chung CP, Yong CS, Chang FC, et al. Stroke etiology is associated with outcome in posterior circulation stroke. Ann Clin Transl Neurol 2015; 2: 510-517.
Jung C, Yoon W, Ahn SJ, Choi BS, Kim JH, Suh SH. The Revascularization scales dilemma: is it right to apply the treatment in cerebral ischemia scale in posterior circulation stroke? AJNR Am J Neuroradiol 2016; 37: 285-289.

Auteurs

A Guenego (A)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.
Department of Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium.

R Bourcier (R)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, L'institut du thorax, Inserm 1087, CNRS, UNIV Nantes, Nantes, France.

M Guillen (M)

Neurovascular Unit, Centre Hospitalier Universitaire Pontchaillou, Rennes, France.

D Weisenburger-Lile (D)

Neurovascular Unit, Foch Hospital, Suresnes, France.

B Lapergue (B)

Neurovascular Unit, Foch Hospital, Suresnes, France.

B Gory (B)

Department of Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, CHRU-Nancy, Nancy, France.
IADI, INSERM U1254, Université de Lorraine, Nancy, France.

S Richard (S)

Stroke Unit, Department of Neurology, Université de Lorraine, CHRU-Nancy, Nancy, France.
INSERM U1116, CHRU-Nancy, Nancy, France.

C Ducroux (C)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

M Piotin (M)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

R Blanc (R)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

J Labreuche (J)

ULR 2694-METRICS: Evaluation Des Technologies De Santé et des Pratiques Médicales, Univ. Lille, CHU Lille, Lille, France.

L Lucas (L)

Neurovascular Unit, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

L Detraz (L)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, L'institut du thorax, Inserm 1087, CNRS, UNIV Nantes, Nantes, France.

M Aubertin (M)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

C Dargazanli (C)

Department of Neuroradiology, Centre Hospitalier Universitaire Gui de Chauliac, Montpellier, France.

A Benali (A)

Department of Neuroradiology, Centre Hospitalier Universitaire Gui de Chauliac, Montpellier, France.

S Vannier (S)

Neurovascular Unit, Centre Hospitalier Universitaire Pontchaillou, Rennes, France.

F Eugene (F)

Department of Neuroradiology, Centre Hospitalier Universitaire Pontchaillou, Rennes, France.

R Lun (R)

Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada.

G Walker (G)

Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada.
Department of Medicine, Division of Neurology, Royal Columbian Hospital, New Westminster, BC, Canada.

A Consoli (A)

Department of Neuroradiology, Foch Hospital, Suresnes, France.

R Fahed (R)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.
Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH